95 related articles for article (PubMed ID: 30272320)
1. MicroRNA‑mRNA integrated analysis based on a case of well‑differentiated thyroid cancer with both metastasis and metastatic recurrence.
Zhang YJ; Ma YS; Xia Q; Yu F; Lv ZW; Jia CY; Jiang XX; Zhang L; Shao YC; Xie WT; Lu GX; Yv XQ; Zhong P; Fu D; Wang XF
Oncol Rep; 2018 Dec; 40(6):3803-3811. PubMed ID: 30272320
[TBL] [Abstract][Full Text] [Related]
2. Distant metastasis as the sole initial manifestation of well-differentiated thyroid carcinoma.
See A; Iyer NG; Tan NC; Teo C; Ng J; Soo KC; Tan HK
Eur Arch Otorhinolaryngol; 2017 Jul; 274(7):2877-2882. PubMed ID: 28382395
[TBL] [Abstract][Full Text] [Related]
3. Pathological tumor-node-metastasis (pTNM) staging for papillary and follicular thyroid carcinomas: a retrospective analysis of 700 patients.
Loh KC; Greenspan FS; Gee L; Miller TR; Yeo PP
J Clin Endocrinol Metab; 1997 Nov; 82(11):3553-62. PubMed ID: 9360506
[TBL] [Abstract][Full Text] [Related]
4. Contribution of p53 gene alterations to development of metastatic forms of follicular thyroid carcinoma.
Sápi Z; Lukács G; Sztán M; Papp J; Oláh E
Diagn Mol Pathol; 1995 Dec; 4(4):256-60. PubMed ID: 8634781
[TBL] [Abstract][Full Text] [Related]
5. Deregulation of microRNA expression in follicular-cell-derived human thyroid carcinomas.
Pallante P; Visone R; Croce CM; Fusco A
Endocr Relat Cancer; 2010 Mar; 17(1):F91-104. PubMed ID: 19942715
[TBL] [Abstract][Full Text] [Related]
6. Identifying differentially expressed genes associated with metastasis of follicular thyroid cancer by cDNA expression array.
Chen KT; Lin JD; Chao TC; Hsueh C; Chang CA; Weng HF; Chan EC
Thyroid; 2001 Jan; 11(1):41-6. PubMed ID: 11272096
[TBL] [Abstract][Full Text] [Related]
7. mRNA and miRNA expression profiling of follicular variant of papillary thyroid carcinoma with and without distant metastases.
Condello V; Torregrossa L; Sartori C; Denaro M; Poma AM; Piaggi P; Valerio L; Materazzi G; Elisei R; Vitti P; Basolo F
Mol Cell Endocrinol; 2019 Jan; 479():93-102. PubMed ID: 30261209
[TBL] [Abstract][Full Text] [Related]
8. Prognostic markers in well differentiated papillary and follicular thyroid cancer (WDTC).
Gillanders SL; O'Neill JP
Eur J Surg Oncol; 2018 Mar; 44(3):286-296. PubMed ID: 28801060
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of quantitative measurement of thyroglobulin mRNA in the follow-up of differentiated thyroid cancer.
Denizot A; Delfino C; Dutour-Meyer A; Fina F; Ouafik L
Thyroid; 2003 Sep; 13(9):867-72. PubMed ID: 14588101
[TBL] [Abstract][Full Text] [Related]
10. Management and outcome of recurrent well-differentiated thyroid carcinoma.
Palme CE; Waseem Z; Raza SN; Eski S; Walfish P; Freeman JL
Arch Otolaryngol Head Neck Surg; 2004 Jul; 130(7):819-24. PubMed ID: 15262757
[TBL] [Abstract][Full Text] [Related]
11. Down-regulation of microRNAs controlling tumourigenic factors in follicular thyroid carcinoma.
Rossing M; Borup R; Henao R; Winther O; Vikesaa J; Niazi O; Godballe C; Krogdahl A; Glud M; Hjort-Sørensen C; Kiss K; Bennedbæk FN; Nielsen FC
J Mol Endocrinol; 2012 Feb; 48(1):11-23. PubMed ID: 22049245
[TBL] [Abstract][Full Text] [Related]
12. [Draft of the best medical treatment in patients with low-risk thyroid cancer].
Vlček P; Nováková D; Vejvalka J; Zimák J; Křenek M; Vošmiková K; Smutný S; Bavor P; Astl J; Lukáš J
Vnitr Lek; 2015 Sep; 61(9):769-77. PubMed ID: 26465275
[TBL] [Abstract][Full Text] [Related]
13. Bioinformatics analyses of significant prognostic risk markers for thyroid papillary carcinoma.
Min XS; Huang P; Liu X; Dong C; Jiang XL; Yuan ZT; Mao LF; Chang S
Tumour Biol; 2015 Sep; 36(10):7457-63. PubMed ID: 25908172
[TBL] [Abstract][Full Text] [Related]
14. The chemokine receptors CXCR4 and CCR7 are associated with tumor size and pathologic indicators of tumor aggressiveness in papillary thyroid carcinoma.
Wagner PL; Moo TA; Arora N; Liu YF; Zarnegar R; Scognamiglio T; Fahey TJ
Ann Surg Oncol; 2008 Oct; 15(10):2833-41. PubMed ID: 18696160
[TBL] [Abstract][Full Text] [Related]
15. Dynamic Risk Estimates of Outcome in Chinese Patients with Well-Differentiated Thyroid Cancer After Total Thyroidectomy and Radioactive Iodine Remnant Ablation.
Shen FC; Hsieh CJ; Huang IC; Chang YH; Wang PW
Thyroid; 2017 Apr; 27(4):531-536. PubMed ID: 28007013
[TBL] [Abstract][Full Text] [Related]
16. Integrated Analysis of Thyroid Cancer Public Datasets Reveals Role of Post-Transcriptional Regulation on Tumor Progression by Targeting of Immune System Mediators.
Geraldo MV; Kimura ET
PLoS One; 2015; 10(11):e0141726. PubMed ID: 26536459
[TBL] [Abstract][Full Text] [Related]
17. Expression of MicroRNAs in Thyroid Carcinoma.
Zhu G; Xie L; Miller D
Methods Mol Biol; 2017; 1617():261-280. PubMed ID: 28540691
[TBL] [Abstract][Full Text] [Related]
18. Integrated analyses of microRNA and mRNA expression profiles in aggressive papillary thyroid carcinoma.
Yang Z; Yuan Z; Fan Y; Deng X; Zheng Q
Mol Med Rep; 2013 Nov; 8(5):1353-8. PubMed ID: 24064622
[TBL] [Abstract][Full Text] [Related]
19. MiR-9 and miR-21 as prognostic biomarkers for recurrence in papillary thyroid cancer.
Sondermann A; Andreghetto FM; Moulatlet AC; da Silva Victor E; de Castro MG; Nunes FD; Brandão LG; Severino P
Clin Exp Metastasis; 2015 Aug; 32(6):521-30. PubMed ID: 26007293
[TBL] [Abstract][Full Text] [Related]
20. Cervical soft tissue recurrence of differentiated thyroid carcinoma after thyroidectomy indicates a poor prognosis.
Gao L; Jiang Y; Liang Z; Zhang L; Mao X; Yang X; Wang Y; Xu J; Liu R; Zhu S; Zhao R; Lai X; Zhang X; Zhang B
Int J Surg; 2017 Dec; 48():254-259. PubMed ID: 28919092
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]